Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 2
2019 2
2020 3
2021 3
2022 1
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Quantitative Perfusion Imaging with Total-Body PET.
Knuuti J, Tuisku J, Kärpijoki H, Iida H, Maaniitty T, Latva-Rasku A, Oikonen V, Nesterov SV, Teuho J, Jaakkola MK, Klén R, Louhi H, Saunavaara V, Nuutila P, Saraste A, Rinne J, Nummenmaa L. Knuuti J, et al. Among authors: latva rasku a. J Nucl Med. 2023 Nov;64(Suppl 2):11S-19S. doi: 10.2967/jnumed.122.264870. J Nucl Med. 2023. PMID: 37918848 Review.
Insulin-stimulated brain glucose uptake correlates with brain metabolites in severe obesity: A combined neuroimaging study.
Rebelos E, Latva-Rasku A, Koskensalo K, Pekkarinen L, Saukko E, Ihalainen J, Honka MJ, Tuisku J, Bucci M, Laurila S, Rajander J, Salminen P, Nummenmaa L, Jansen JF, Ferrannini E, Nuutila P. Rebelos E, et al. Among authors: latva rasku a. J Cereb Blood Flow Metab. 2024 Mar;44(3):407-418. doi: 10.1177/0271678X231207114. Epub 2023 Oct 12. J Cereb Blood Flow Metab. 2024. PMID: 37824728 Free PMC article.
Obesity risk is associated with brain glucose uptake and insulin resistance.
Pekkarinen L, Kantonen T, Rebelos E, Latva-Rasku A, Dadson P, Karjalainen T, Bucci M, Kalliokoski K, Laitinen K, Houttu N, Kirjavainen AK, Rajander J, Rönnemaa T, Nummenmaa L, Nuutila P. Pekkarinen L, et al. Among authors: latva rasku a. Eur J Endocrinol. 2022 Nov 30;187(6):917-928. doi: 10.1530/EJE-22-0509. Print 2022 Dec 1. Eur J Endocrinol. 2022. PMID: 36288097 Free PMC article.
Finnish-specific AKT2 gene variant leads to impaired insulin signalling in myotubes.
Mäkinen S, Datta N, Rangarajan S, Nguyen YH, Olkkonen VM, Latva-Rasku A, Nuutila P, Laakso M, Koistinen HA. Mäkinen S, et al. Among authors: latva rasku a. J Mol Endocrinol. 2023 Jan 4;70(2):e210285. doi: 10.1530/JME-21-0285. Print 2023 Feb 1. J Mol Endocrinol. 2023. PMID: 36409629 Free PMC article.
Predicting Skeletal Muscle and Whole-Body Insulin Sensitivity Using NMR-Metabolomic Profiling.
Klén R, Honka MJ, Hannukainen JC, Huovinen V, Bucci M, Latva-Rasku A, Venäläinen MS, Kalliokoski KK, Virtanen KA, Lautamäki R, Iozzo P, Elo LL, Nuutila P. Klén R, et al. Among authors: latva rasku a. J Endocr Soc. 2020 Mar 11;4(4):bvaa026. doi: 10.1210/jendso/bvaa026. eCollection 2020 Apr 1. J Endocr Soc. 2020. PMID: 32232183 Free PMC article.
Lower abdominal adipose tissue cannabinoid type 1 receptor availability in young men with overweight.
Pekkarinen L, Kantonen T, Oikonen V, Haaparanta-Solin M, Aarnio R, Dickens AM, von Eyken A, Latva-Rasku A, Dadson P, Kirjavainen AK, Rajander J, Kalliokoski K, Rönnemaa T, Nummenmaa L, Nuutila P. Pekkarinen L, et al. Among authors: latva rasku a. Obesity (Silver Spring). 2023 Jul;31(7):1844-1858. doi: 10.1002/oby.23770. Obesity (Silver Spring). 2023. PMID: 37368516
Insulin Resistance Is Associated With Enhanced Brain Glucose Uptake During Euglycemic Hyperinsulinemia: A Large-Scale PET Cohort.
Rebelos E, Bucci M, Karjalainen T, Oikonen V, Bertoldo A, Hannukainen JC, Virtanen KA, Latva-Rasku A, Hirvonen J, Heinonen I, Parkkola R, Laakso M, Ferrannini E, Iozzo P, Nummenmaa L, Nuutila P. Rebelos E, et al. Among authors: latva rasku a. Diabetes Care. 2021 Mar;44(3):788-794. doi: 10.2337/dc20-1549. Epub 2021 Jan 14. Diabetes Care. 2021. PMID: 33446523 Free PMC article.
Effects of 6 weeks of treatment with dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: A randomized, placebo-controlled, exploratory study.
Oldgren J, Laurila S, Åkerblom A, Latva-Rasku A, Rebelos E, Isackson H, Saarenhovi M, Eriksson O, Heurling K, Johansson E, Wilderäng U, Karlsson C, Esterline R, Ferrannini E, Oscarsson J, Nuutila P. Oldgren J, et al. Among authors: latva rasku a. Diabetes Obes Metab. 2021 Jul;23(7):1505-1517. doi: 10.1111/dom.14363. Epub 2021 Mar 12. Diabetes Obes Metab. 2021. PMID: 33625777 Free article. Clinical Trial.
Both sedentary time and physical activity are associated with cardiometabolic health in overweight adults in a 1 month accelerometer measurement.
Sjöros T, Vähä-Ypyä H, Laine S, Garthwaite T, Lahesmaa M, Laurila SM, Latva-Rasku A, Savolainen A, Miikkulainen A, Löyttyniemi E, Sievänen H, Kalliokoski KK, Knuuti J, Vasankari T, Heinonen IHA. Sjöros T, et al. Among authors: latva rasku a. Sci Rep. 2020 Nov 25;10(1):20578. doi: 10.1038/s41598-020-77637-3. Sci Rep. 2020. PMID: 33239818 Free PMC article. Clinical Trial.
15 results